BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15977519)

  • 1. Timing of aspirin and secondary preventative therapies in acute stroke: support for use of stroke units.
    Reid J; MacLeod MJ; Williams D
    Scott Med J; 2005 May; 50(2):69-72. PubMed ID: 15977519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today?
    Sandercock PA
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1461-4. PubMed ID: 14617697
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke.
    Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
    Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):370-7. PubMed ID: 22023326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.
    Suri MF; Hussein HM; Abdelmoula MM; Divani AA; Qureshi AI
    Med Sci Monit; 2008 Oct; 14(10):PI39-44. PubMed ID: 18830204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of stroke in Auckland Hospital in 1996.
    Charleston AJ; Barber PA; Bennett P; Spriggs DA; Harris RG; Anderson NE
    N Z Med J; 1999 Mar; 112(1083):71-4. PubMed ID: 10210307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
    Burke JP; Sander S; Shah H; Zarotsky V; Henk H
    Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of acute stroke unit and short-term stroke ward with early supported discharge decreases mortality and complications after acute ischemic stroke.
    Suwanwela NC; Eusattasak N; Phanthumchinda K; Piravej K; Locharoenkul C
    J Med Assoc Thai; 2007 Jun; 90(6):1089-96. PubMed ID: 17624201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
    Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
    Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.
    Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C;
    Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time from hospital admission to CT brain in acute ischaemic stroke.
    Mulroy M; Murphy B; Murphy SP; Marsden P; Fallon C; Murphy S
    Ir Med J; 2011 Jun; 104(6):185-7. PubMed ID: 22111397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin resistance is associated with increased stroke severity and infarct volume.
    Oh MS; Yu KH; Lee JH; Jung S; Kim C; Jang MU; Lee J; Lee BC
    Neurology; 2016 May; 86(19):1808-17. PubMed ID: 27060166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin resistance are associated with long-term recurrent stroke events after ischaemic stroke.
    Zhang N; Wang Z; Zhou L
    Brain Res Bull; 2017 Sep; 134():205-210. PubMed ID: 28842303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.
    Grau AJ; Reiners S; Lichy C; Buggle F; Ruf A
    Stroke; 2003 Apr; 34(4):849-54. PubMed ID: 12637702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
    Dengler R; Diener HC; Schwartz A; Grond M; Schumacher H; Machnig T; Eschenfelder CC; Leonard J; Weissenborn K; Kastrup A; Haberl R;
    Lancet Neurol; 2010 Feb; 9(2):159-66. PubMed ID: 20060783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy.
    Cha JK; Jeon HW; Kang MJ
    Eur J Neurol; 2008 Dec; 15(12):1304-8. PubMed ID: 19049546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin resistant patients with recent ischemic stroke.
    Castilla-Guerra L; Navas-Alcántara MS; Fernández-Moreno MC
    Rev Clin Esp (Barc); 2014 Apr; 214(3):145-9. PubMed ID: 24211052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.